卡托普利联合缬沙坦辅治慢性心力衰竭33例疗效观察

目的：探讨卡托普利联合缬沙坦治疗慢性心力衰竭的临床效果。方法选择本院慢性心力衰竭患者共65例，上述患者随机分为两组，观察组和对照组。两组在常规治疗基础上，对照组给予卡托普利治疗，观察组给予卡托普利和缬沙坦治疗。观察两组患者心功能改变情况。结果观察组总有效率96.9%；对照组治总有效率71.8%；观察组总有效率高于对照组，差异有统计学意义（P〈0.05）。观察组治疗后左室射血分数、左室舒张末期内径分别与对照组治疗后比较，差异有统计学意义（P〈0.05）。结论卡托普利联合缬沙坦辅治慢性心力衰竭疗效显著，值得借鉴。

Clinical effect of captopril combined with valsartan on 33 cases with chronic heart failure

Objective To investigate the clinical effect of captopril combined with valsartan on chronic heart failure. Methods 65 cases with chronic heart failure were selected and randomly divided into observation group and control group. The two groups were given routine anti heart failure treatment, captopril was given to the control group, and captopril combined with valsartan was given to observation group at the same time. the efficacy of the two groups was evaluated. cardiac function change was observed before and after treatment. Results The total effective rate in the observation group was 96.9%, The total effective rate in the control group was71.8%, the total effective rate in the observation group was higher than thatin the control group, the difference was statistically significant （P〈0.05）. The left ventricular ejection fraction and left ventricular end diastolic diameter in the observation group after treatment compared with those in the control group after treatment, the difference was statistically significant （P〈0.05）. Conclusion The curative effect of captopril combined with valsartan on heart failure complicated with ventricular arrhythmia treatment is significant, and captopril combined with valsartan is helpful to improve clinical symptoms and signs.